in effect
This is a presidential executive order (Executive Order 14216, signed February 18, 2025). It states a policy that the administration will work to ensure reliable, more affordable access to in vitro fertilization (IVF), and it directs a White House official to study and recommend ways to do so.
By itself, the order does not change any existing law, regulation, or insurance rule, and it does not directly lower IVF prices. Its one concrete action is a deadline: within 90 days, the Assistant to the President for Domestic Policy must give the President a list of policy recommendations for protecting IVF access and reducing out-of-pocket and health-plan costs. The order cites that IVF can cost $12,000 to $25,000 per cycle and states a goal of easing “unnecessary statutory or regulatory burdens.” Standard closing provisions say it must be carried out consistent with existing law and available funding, and that it creates no legally enforceable rights.
The immediate assignment falls on the Assistant to the President for Domestic Policy, who must produce the recommendations. Any practical effect on people facing fertility challenges, IVF providers, or health plans would depend on later actions built from those recommendations, not on this order alone.